ISPUB.com / IJAPA/3/1/3051
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Academic Physician Assistants
  • Volume 3
  • Number 1

Original Article

Dramatic And Long Lasting Efficiency (13 Years) Of Oral 5 Aspirin

B Maroy

Keywords

5 aminosalicylate, corticosteroids complications, depression, left-sided, severe, treatment, ulcerative colitis

Citation

B Maroy. Dramatic And Long Lasting Efficiency (13 Years) Of Oral 5 Aspirin. The Internet Journal of Academic Physician Assistants. 2002 Volume 3 Number 1.

Abstract

Introduction: Could 5 ASA be an option in case of cortico-resistant and/or intolerant ulcerative colitis?
Case report: A 55-year-old woman was referred for a recent, moderately severe, left-sided ulcerative colitis. The response to corticotherapy was initially fair, then mediocre, complicated by a severe depression. The patient rejected colectomy. Corticotherapy was switched to 3g/d oral PentasaR. Bleeding stopped and rectal mucosa switched to pink within 3 days. Colonoscopy, performed 10 days later, evidenced deep and large ulcerations in the process of cicatrization.
After 13 years of 5-ASA, the patient remains asymptomatic with progressive disappearance of mucosal scars.
Conclusion: Oral 5 ASA could be worth a trial in some cases of severe flare-ups of ulcerative colitis when corticoids are inefficient or poorly tolerated and if colectomy is not possible, as an alternative to cyclosporin. The quick and long-lasting efficiency in the present case are to be emphasized.

 

Introduction

Five-ASA is usually used per os only for moderate intensity flares-up of ulcerative colitis (UC)(1). For more severe cases, corticotherapy is the corner stone of the medical treatment (1, 2). However, its efficiency is not constant (3), neither is its tolerance. In these cases, surgery is usually mandatory (1). Nevertheless, the patient may decline the operation. Ciclosporine is another option, at least for the short term (4). We report herein, among a severe flare-up of UC, the dramatic and very long lasting effect of oral 5ASA.

Case Report

A 55-year-old woman was seen for a, 15 stools per day, bloody diarrhea, evolving since 4 month. A cautious colonoscopy disclosed a typical UC pattern with moderately deep, round ulcerations and a very congestive mucosa, stopping abruptly after the splenic flexure. Pathology data were evocative of UC. Upper GI endoscopy, gastric and duodenal pathology data and barium follow-through were normal. Intra muscular methyl-prednisolone 120 mg o.d. during 5 days, improved the diarrhea and was switched to 60 mg prednisone p.o. However, 10 days later, the result was poor, with 8 bloody stool, abdominal colicky pain, anorexia, fatigue and weight loss, together with the occurrence of a severe depression. Proctoscopy disclosed a dark red, very congestive, haemorrhagic rectal mucosa. A trial of tixocortol enema, 250 mg o.d, was poorly tolerated and stopped. She declined a trial of 5 ASA enemas. An antidepressant, medifoxamine 50 mg t.i.d., did not improve the depression.

Moreover, this depression made her very uncooperative and difficult to manage. Because of worsening and vomiting, IM Methyl-prednisolone 120 mg o.d. was started again, leading to a moderate and transient improvement.

However, her state worsened again with 5 bloody stools a day. Temperature was 38°C, the pulse rate 90/MN with a persistent weight loss. Hemoglobin was 90 g/l, WBC 10,000G/l, ESR 47 mm/1h, serum proteins 47 g/l and albumin 23 g/l. Therefore, a colectomy was suggested, but the patient, very depressive, rejected it absolutely. Corticotherapy was stopped and 5 ASA, as PentasaR, 3 g/d p.o. was started. Dramatically, within three days, bloody stools disappeared and depression as well. Diarrhea decreased more slowly over 15 days. Three days after starting 5 ASA, proctoscopy disclosed a dramatic improvement of the mucosal pattern. Its color had switched from dark red to a normal pink. A cautious colonoscopy, performed one week later, disclosed an impressive worsening of the ulcerations. They looked deep, rail-shaped, with numerous pseudo-polyps and large surfaces of naked muscularis propria. These lesions contrasted with an almost normal mucosa, pink colored, moderately edematous, not friable nor haemorrhagic. Reepithelialization was beginning at the margins of the ulcerations. Right colon and ileum were normal. Unfortunately, no picture was taken at the moment. Microscopic examination disclosed severe, deep UC lesions with round cell infiltration, edema and numerous cryptic abscesses, contrasting with an almost normal superficial epithelium. The general state of health normalized within a month and biological data within three months. A control colonoscopy showed only an important cicatricial pseudo-polyposis of the left colon, covered by a normal-appearing mucosa. Microscopic examination confirmed this improvement.

Since that time she remained asymptomatic, except for mild attacks when 5 ASA dosage was tapered to less than 2 g/d. Depression did not recur. The last control showed a normal mucosa, with an important regression of the scars. Microscopic examination was almost normal.

Discussion

To the best of my knowledge, the use of 5 ASA per os for severe flare-up of UC has not been studied. As a local treatment, its efficiency is well known (1,2,3, 5). However, some authors state, without further details, that they use salazopyrine (3) or oral 5 ASA, in association with corticoids, among severe flare-up. It is, therefore, difficult to know which is the relative importance of the salicylate compound (3). Most frequently, corticotherapy is efficient and well tolerated (2). In other cases, urgent colectomy (1, 3, 5, 6) offers a high rate of cure. It should not be postponed, a too long medical treatment leading to an increase of operative death (2, 3, 6,7,8). However, in case of a disputable efficiency, of a left-sided colitis (7, 10) and of an uncertainty on its exact type (6,7, 11), the decision to operate on may be difficult (7, 9).

The trial of ciclosporin is a recent option but it is costly, its tolerance is far from perfect and the later treatment is not yet established (4).

Clinical and biological criteria remain useful but their sensitivity for predicting the necessity of surgery is questioned (1, 8, 10, 11, 13, 14). The safety and the importance of a cautious colonoscopy for the decision to operate on have been underlined (9, 14, 15). The shape and the depth of the ulcerations (9, 11, 14), have a great prognostic value. The present case is in keeping with the notion that the anatomical state can be severely worsening when the improvement is not clear-cut (10, 11).

Sometimes, corticosteroids induce a depression (16,17,18,19) which worsens the general state of health and can contribute to a poor cooperation of the patient, like in the present case. The depressive symptoms arise usually within the two first weeks of treatment (19). Female gender (19), systemic lupus erythematosus (18, 19), total daily dose (18) and the peak concentration of corticosteroids (20), increase the probability of depression, but a previous episode of psychiatric reaction, even if steroid-induced (19) does not.

The diagnosis of ulcerative colitis is certain in the present case because of the typical macroscopic and microscopic features. A 4-month evolution before the diagnosis, the left-sided continuous extension with a clear-cut upper limit, microscopic data and later attacks excludes a transient infectious colitis (1). A Crohn's disease is excluded by the initial features and the follow-up. The clinical and biological data allow to classify the present attack as severe, according to the established criteria (7, 13). The type of the ulcerations is evocative of UC and confirms, a posteriori, its severity (9, 11, 14).

The dramatic effect of oral 5 ASA led to the resolution of this severe flare-up. The resolution of the mucosal congestion at proctoscopy was particularly impressive, taking in account the delay of 3 days. It is most improbable that the 8 days of IM corticotherapy, leading to a disputable effect, could be responsible, through a delayed action, for the long-lasting resolution of the UC. Moreover, this long-lasting efficiency of 5 ASA is to be underlined.

Summary

In summary, 5 ASA could be efficient in some cases of severe cortico-resistant and/or cortico-intolerant flare-up of UC. This possibility could by of a peculiar interest in developing countries where ciclosporin is not available. However, 5ASA may worsen an UC flare-up. (21).

Correspondence to

Dr B.Maroy Maison Médicale de Lunesse 24 rue Chabernaud F 16340 L'Isle d'Espagnac FRANCE Tel: +33 (0)545940094 Fax: +33 (0)45942500 E mail: maroyg@aol.com

References

1. Jewell DP. Ulcerative Colitis. In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Diseases 5th edition, Philadelphia: WB Saunders, 1993:1320-4.
2. Jewell DP. Corticosteroids for the management of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1989;18:21
3. Morel P, Hawker PC, Allan MD et al. Management of acute colitis in inflammatory bowel disease. World J Surg 1986;10:814-9.
4. Stack WA, Long RG, Hawkey CJ. Short-and long-term outcome of patients treated with cylosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998;12:973-8.
5. McPhee MS, Swan JT, Biddle WL et al. Proctocolitis unresponsive to conventional therapy. Response to 5-Aminosalicylic acid enema. Dig Dis Sci 1987;32:76S-81S.
6. Goligher JC, Hoffman DC, de Dombal FT. Surgical treatment of severe attacks of ulcerative colitis with special reference to the advantages of early operation. Br Med J 1970;4:703-6.
7. Jewell DP, Caprili R, Mortensen N et al. Indications and timing of surgery for severe ulcerative colitis. Gastroenterology Int 1991;4:161-4.
8. Truelove SC, Willoughby CP, Lee EG et al. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978;2:1087-8
9. Alemayehu G, Jarnerot G. Colonoscopy during attacks of severe ulcerative colitis is a safe procedure and of great value in clinical decision making. Am J Gastroenterol 1991;86:187-90.
10. Lennard-Jones JE, Ritchie JK, Hilder W et al. Assessment of severity in colitis: a preliminary study. Gut 1975;16:579-94.
11. Buckell NA, Williams GT, Bartram CI et al. Depth of ulceration in ulcerative colitis. Correlations with outcome and clinical and radiologic features. Gastroenterology 1980;79:19-25.
12. Pera A, Bellando P, Ponti et al. Colonoscopy in inflammatory bowel disease. Gastroenterology 1987;92:181-5.
13. 13.Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on therapeutic trial Br Med J 1955;1:1041-8.
14. Carbonnel F, Lavergne A, Lemann M et al. Value of colonoscopy in assessment of severity of lesions in attacks of ulcerative colitis. Gastroenterology 1991;100:A201.
15. Rambaud JC, Carbonnel F, Bitoun A et al. Colonoscopy to assess ulcerative colitis.(letter) Lancet 1996,348:625.
16. Kershner P, Wang Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989;30:135-9.
17. Ling MHM, Pery PJ, Tsuang MT. Side effects of corticosteroids therapy: psychiatric aspects. Arch Gen Psychiatry 1981;38:471-7.
18. The Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharm Therapeutics 1972;13:694-8.
19. Kershner P, Wang-Cheng R. Psychiatric side effects of steroid therapy. Psychosomatics 1989;30:135-9.
20. Glynne-Jones R, Vernon CC. Is steroid psychosis preventable by divided doses? (letter) Lancet 1986;2:1404.
21. Kapur KC, Williams GT, Allisson MC. Mesalazine induced exacerbation of ulcerative colitis. Gut 1995;37:838-9.

Author Information

Bernard Maroy, MD

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy

Close

Enter the site

Login

Password

Remember me

Forgot password?

Login

SIGN IN AS A USER

Use your account on the social network Facebook, to create a profile on BusinessPress